Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
04/23/2008 | EP1421827A4 Organic light emitting devices having carrier blocking layers comprising metal complexes |
04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
04/23/2008 | EP0998459B1 Pyridine derivatives |
04/23/2008 | EP0984928B1 Heterocyclic nitrato derivatives |
04/23/2008 | CN101166725A Pyridylacetic acid compound |
04/23/2008 | CN101166724A Sulfonylamino(thio)carbonyl compounds in the form of herbicides or plant growth regulators |
04/23/2008 | CN101166722A Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles |
04/23/2008 | CN101166576A Catalyst precursor for the production of olefins with an odd number of carbon atoms, process for its preparation and production method for such olefins |
04/23/2008 | CN101165061A Hetero triazine compounds |
04/23/2008 | CN101165054A Method for synthesizing 1-hydroxy-1,2,4,5-tetrapyridylcyclohexane |
04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
04/23/2008 | CN100383123C 4-hydroxylic pyridine and production process thereof |
04/23/2008 | CN100383110C Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases |
04/22/2008 | US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
04/22/2008 | US7361773 dealkylation of a benzodioxane aniline in presence of chloroethanol |
04/22/2008 | US7361679 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
04/22/2008 | US7361674 7, 8 and 9-substituted tetracycline compounds |
04/22/2008 | US7361671 E.g.,(6-Ethyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrr (2,3-b)pyridin-1-yl)acetic acid; interacts with and inhibits aldose reductase; antidiabetic agents and diabetic complications; gout; hypoglycemic and antiarthritic |
04/22/2008 | US7361655 Pharmaceutically effective compounds |
04/22/2008 | US7361198 oxidative hair colorants; which particularly in combination with the often used p-phenylenediamines would give blue shades and afford oxidation colorants with high resistance to external influences, particularly to frequent washing and sunlight |
04/22/2008 | CA2388759C Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
04/22/2008 | CA2180816C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients |
04/17/2008 | WO2008046003A2 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
04/17/2008 | WO2008045671A1 Matrix metalloprotease inhibitors |
04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
04/17/2008 | WO2008044713A1 Substituted pyridinecarboxanilide derivative or salt thereof, and agricultural or horticultural agent, and use thereof |
04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
04/17/2008 | WO2008044339A1 Therapeutic/preventive agent for intraocular disease containing statin compound |
04/17/2008 | WO2008044217A2 2-aminocarbonyl-pyridine derivatives |
04/17/2008 | WO2008044099A1 Charge transfer complexes in the treatment of inflammatory bowel diseases |
04/17/2008 | WO2008043492A1 Method for producing alkaline (meth)acrylamides |
04/17/2008 | WO2008043446A1 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl)]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrate |
04/17/2008 | WO2008022164A3 Pyrazine compounds, their use and methods of preparation |
04/17/2008 | WO2008022046A3 Dicer substrate rna peptide conjugates and methods for rna therapeutics |
04/17/2008 | WO2008011117A3 Antiviral protease inhibitors |
04/17/2008 | WO2007146323A3 Substituted cyanopyridines as protein kinase inhibitors |
04/17/2008 | WO2007115836A3 Tetrahydronaphtol-derivatives and use thereof |
04/17/2008 | WO2007056517A3 Pharmaceutical salts and polymorphs of n- (5-chl0r0-2-pyridinyl) -2- [ [4- [ (dimethylamino) iminomethyl] benzoyl] amino] -5-meth oxy-benzamide, a factor xa inhibitor |
04/17/2008 | US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
04/17/2008 | US20080090996 Thrombopoietin mimetics |
04/17/2008 | US20080090875 Analgesics, antipyretics, antiinflammatory agents; 4-(4-chlorophenyl)-5-(4-methanesulfonylphenyl)-1,2-dihydropyrazole-3-thione for example; cyclooxygenase-2 (COX-2) inhibitors; side effect reduction |
04/17/2008 | US20080090863 Melanin Concentrating Hormone (MCH) receptor antagonists; eating disorder, obesity, psychological disorders, drug addiction, diabetes, cardiovascular disorders; 2-(cyclohexyl(alkyl)amino)pyridines such as 3-chloro-4-fluoro-N-(cis-4-[(4-methoxypyridin-2-yl)amino]cyclohexyl)benzamide |
04/17/2008 | US20080090857 Statin derivatives |
04/17/2008 | US20080090856 useful for the modulation of kinase activity of C-Abl, c-Kit, VEGFR, PDGFR, Flt-3, c-MET, HER family, Raf kinase family and disease polymorphs thereof; hyperproliferative diseases, cancer; 1-(5-(4-(1H-pyrazol-4-yl)pyrimidin-2-yloxy)-2-fluorophenyl)-3-(3-isopropyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)urea |
04/17/2008 | US20080090854 Cxcr2 inhibitors |
04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
04/17/2008 | US20080090842 Novel pyridyl cyanoguanidine compounds |
04/17/2008 | US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders |
04/17/2008 | US20080090822 Piperazine Derivatives As Glyt 1 Inhibitors |
04/17/2008 | US20080090794 Potassium Channel Inhibitors |
04/17/2008 | US20080090787 Thrombopoietin mimetics |
04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
04/17/2008 | CA2666171A1 Method for producing basic (meth)acrylamides |
04/17/2008 | CA2666170A1 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrate |
04/17/2008 | CA2664579A1 2-aminocarbonyl-pyridine derivatives |
04/16/2008 | EP1911776A1 Polyacrylamide gel for electrophoresis, polyacrylamide gel electrophoresis method using the same, method of producing the same and acrylamide compound |
04/16/2008 | EP1911762A1 Amino alcohols and their use as renin inhibitors |
04/16/2008 | EP1911751A1 Amide derivative and pesticide containing such compound |
04/16/2008 | EP1911746A1 The substance having antioxidant, geroprotective and anti-ischemic activity and method for preparing thereof |
04/16/2008 | EP1911740A1 Potassium channel modulators |
04/16/2008 | EP1910304A2 Therapeutic agents |
04/16/2008 | EP1910295A1 Substituted pyridocarboxamides as inhibitors of plasminogen activator inhibitor 1 (pai-1) |
04/16/2008 | EP1910294A1 A process for the preparation of substituted phenyl ether compounds and rosiglitazone |
04/16/2008 | EP1910293A1 Isotopically substituted proton pump inhibitors |
04/16/2008 | EP1910279A2 Non-nucleoside anti-hepacivirus agents and uses thereof |
04/16/2008 | EP1910277A1 Quadratic acid derivatives in the form of a protein kinase inhibitors |
04/16/2008 | EP1910272A1 Renin inhibitors |
04/16/2008 | EP1909572A2 Potassium channel inhibitors |
04/16/2008 | EP1529240A4 Electrolytes for electrooptic devices comprising ionic liquids |
04/16/2008 | CN101163678A 吡啶基甲基砜衍生物 Pyridyl methyl sulfone derivative |
04/16/2008 | CN101163669A Acetylene derivatives |
04/16/2008 | CN101163667A Phenyl ethyne compounds |
04/16/2008 | CN101163662A Phenylacetylene derivatives having mglur5 receptor affinity |
04/16/2008 | CN101161653A Method for preparing novel Pranoprofen key intermediates |
04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
04/16/2008 | CN101161343A A novel catalyst for synthesizing pyridine base as well as its preparing and using method |
04/16/2008 | CN100381424C Biaryl sulfonamides and methods for using same |
04/16/2008 | CN100381418C Gelling agents |
04/16/2008 | CA2683910A1 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
04/15/2008 | USRE40245 Gyrase inhibitors and uses thereof |
04/15/2008 | US7358397 By cleavage and reduction of a halogenated p-hydroxyazobenzene formed by diazotizing an aniline and reacting with a halogenated phenol; intermediates for fluoro-containing agrochemicals or chronic bronchitis agents |
04/15/2008 | US7358359 Antibacterial agents |
04/15/2008 | US7358264 Statine derivatives for the treatment of Alzheimer's disease |
04/15/2008 | US7358257 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents |
04/15/2008 | CA2411468C Thrombopoietin mimetics |
04/15/2008 | CA2276012C 6-(nonsubstituted or substituted) phenoxy picolinic acid, process for producing the same and agricultural or horticultural fungicide using the same |
04/15/2008 | CA2211981C Production of enantiomerically enriched ortho-substituted .alpha.,.alpha.-diaromatic methanols |
04/10/2008 | WO2008042429A1 Improved electrochemical reduction of halogenated 4-aminopicolinic acids |
04/10/2008 | WO2008041751A1 Pharmaceutical preparation for treating fibromyalgia |
04/10/2008 | WO2008041090A1 Malanin concentrating hormone receptor-1 antagonist pyridinones |
04/10/2008 | WO2008041088A2 N-hydroxy benzamides with antitumor activity |
04/10/2008 | WO2008040934A1 Hdac inhibitors |
04/10/2008 | WO2008040651A1 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents |
04/10/2008 | WO2007136875A3 Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
04/10/2008 | WO2007107345A3 PROCESS FOR PREPARING l-HALO-2,7-NAPHTHYRIDINYL DERIVATIVES |
04/10/2008 | US20080085924 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
04/10/2008 | US20080085900 Sulfonylguanidine compounds and pharmaceutical uses thereof |
04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |